Reyon Pharmaceutical to prepay KRW 110,448,600 of debt before maturity on put option exercise

PUBT · 2d ago
Reyon Pharmaceutical to prepay KRW 110,448,600 of debt before maturity on put option exercise
  • Reyon Pharmaceutical set an early buyback of KRW 100,000,000 of its 3rd private convertible bond before maturity.
  • Repurchase price KRW 110,448,600, reflecting principal plus interest; payment scheduled for Oct. 26, 2026.
  • Transaction triggered by bondholders’ put option; bonds to be retired following the buyback.
  • Outstanding principal balance to fall to KRW 84.9 billion from KRW 85 billion.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Reyon Pharmaceutical Co. Ltd. published the original content used to generate this news brief via DART, the regulatory disclosure system operated by the South Korea Financial Supervisory Service (FSS) (Ref. ID: 20260928000281), on September 28, 2026, and is solely responsible for the information contained therein.